Browse studies

Find your next paid study

27,333 recruiting studies available now

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

This prospective, multi-center, randomized, controlled modified platform Trial compares Purified Native Type 1 Collagen Extracellular Matrix with Polyhexamethy…

Diabetic Foot Ulcer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

OrganogenesisNCT06618612

Testosterone Deficiency and Endothelial Dysfunction in Spinal Cord Injury Related Cardiovascular Disease Mechanistic Insights and Therapeutic Prospects

Heart attacks and strokes are among the most common causes of premature death in individuals living with spinal cord injury (SCI) and appear to occur earlier i…

Spinal Cord InjuriesEndothelial DysfunctionTestosterone Deficiency

Estimated

~$10 – $750

Actual pay is set by the research site.

Craig HospitalNCT07227740

Observational

Genetic Biomarkers of Intermittent Hypoxia-Induced Respiratory Motor Plasticity in Chronic SCI

Acute intermittent hypoxia (AIH) involves brief (1 min), repeated episodes (\~15) of breathing low oxygen air to stimulate spinal neuroplasticity. Animal and h…

Spinal Cord Injuries

Estimated

~$10 – $750

Actual pay is set by the research site.

University of FloridaNCT06011876

Observational

Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Prostate Tumors

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT01727284

Phase 2

Alternating Treatment Plans for Participants With Advanced Thoracic/Head & Neck Cancers (ATATcH)

The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunothe…

Head and Neck CancerLung Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Rutgers, The State University of New JerseyNCT05358548

Phase 1

A Dose-Finding and Proof-of-Concept Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

The goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and have amyloidos…

AL AmyloidosisAmyloidosis

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT05145816

Observational

PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men

This type 3 Hybrid Effectiveness-Implementation study will evaluate PrEP \& Soccer, a multicomponent and multilevel implementation strategy delivered by a phar…

HIV PreventionLatino Men Who Have Sex With MenPharmacy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT07263048

Phase 1

Phase 1/2 Study of REGN4336 (a PSMAxCD3 Bispecific Antibody) Administered Alone or in Combination With REGN5678 (a PSMAxCD28 Bispecific Antibody) in Patients With Metastatic Castration-Resistant Prostate Cancer

This study is researching an investigational drug called REGN4336 both alone or together with another investigational drug called REGN5678. The study is focuse…

Metastatic Castration-resistant Prostate Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT05125016

Phase 2

A Phase 2 Trial of Nemtabrutinib in Combination With Brexu-cel for Patients With Relapsed/Refractory Mantle Cell Lymphoma

This phase II trial tests the effect of nemtabrutinib in combination with brexucabtagene autoleucel (brexu-cel) in treating patients with mantle cell lymphoma …

Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Vanderbilt-Ingram Cancer CenterNCT07673367

Phase 3

A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-1)

The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous …

Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

EMD Serono Research & Development Institute, Inc.NCT07332481

Phase 2

A Phase 2 Study Evaluating the Efficacy and Safety Agent AUR103 Calcium in Patients With Advanced, Well or Moderately Differentiated Neuroendocrine Tumours (BHARAT-3)

A phase 2 Study Evaluating the Efficacy and Safety of Single Agent AUR103 Calcium in Patients with Advanced, Well or Moderately differentiated Neuroendocrine T…

Neuroendocrine (NE) TumorsAdvanced NET of GI Origin

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Aurigene Discovery Technologies LimitedNCT07640737

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multipl…

AL AmyloidosisMultiple Myeloma

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07850284